Publication:
INTRAVENOUS VERSUS SUBCUTANEOUS TOCILIZUMAB IN A SERIES OF 471 PATIENTS WITH GIANT CELL ARTERITIS

Simple item page
dc.conference.dateJUN 01-04, 2022
dc.conference.titleEULAR European Congress of Rheumatology (EULAR)
dc.contributor.authorSanchez-Bilbao, L.
dc.contributor.authorLoricera, J.
dc.contributor.authorCastaneda, S.
dc.contributor.authorMoriano, C.
dc.contributor.authorNarvaez, J.
dc.contributor.authorAldasoro, V.
dc.contributor.authorMaiz, O.
dc.contributor.authorMelero, R.
dc.contributor.authorVilla-Blanco, I.
dc.contributor.authorVela-Casasempere, P.
dc.contributor.authorRomero-Yuste, S.
dc.contributor.authorCallejas-Rubio, J. L.
dc.contributor.authorDe Miguel, E.
dc.contributor.authorGalindez-Agirregoikoa, E.
dc.contributor.authorSivera, F.
dc.contributor.authorFernandez-Lopez, C.
dc.contributor.authorGalisteo, C.
dc.contributor.authorFerraz-Amaro, I.
dc.contributor.authorSanchez-Martin, J.
dc.contributor.authorCalderon-Goercke, M.
dc.contributor.authorHernandez, J. L.
dc.contributor.authorGonzalez-Gay, M. A.
dc.contributor.authorBlanco, R.
dc.contributor.authoraffiliation[Sanchez-Bilbao, L.] Hosp Univ Marques Valdecilla, Rheumatol, Santander, Spain
dc.contributor.authoraffiliation[Loricera, J.] Hosp Univ Marques Valdecilla, Rheumatol, Santander, Spain
dc.contributor.authoraffiliation[Sanchez-Martin, J.] Hosp Univ Marques Valdecilla, Rheumatol, Santander, Spain
dc.contributor.authoraffiliation[Calderon-Goercke, M.] Hosp Univ Marques Valdecilla, Rheumatol, Santander, Spain
dc.contributor.authoraffiliation[Gonzalez-Gay, M. A.] Hosp Univ Marques Valdecilla, Rheumatol, Santander, Spain
dc.contributor.authoraffiliation[Blanco, R.] Hosp Univ Marques Valdecilla, Rheumatol, Santander, Spain
dc.contributor.authoraffiliation[Castaneda, S.] Hosp Princesa, Rheumatol, Madrid, Spain
dc.contributor.authoraffiliation[Moriano, C.] Complejo Asistencial Leon, Rheumatol, Leon, Spain
dc.contributor.authoraffiliation[Narvaez, J.] Hosp Bellvitge Princeps Espanya, Rheumatol, Barcelona, Spain
dc.contributor.authoraffiliation[Aldasoro, V.] Complejo Hosp Navarra, Rheumatol, Navarra, Spain
dc.contributor.authoraffiliation[Maiz, O.] Hosp Univ Donostia, Rheumatol, San Sebastian, Spain
dc.contributor.authoraffiliation[Melero, R.] Complexo Hosp Vigo, Rheumatol, Vigo, Spain
dc.contributor.authoraffiliation[Villa-Blanco, I.] Hosp Sierrallana, Rheumatol, Torrelavega, Spain
dc.contributor.authoraffiliation[Vela-Casasempere, P.] Hosp Gen Univ Alicante, Rheumatol, Alicante, Spain
dc.contributor.authoraffiliation[Romero-Yuste, S.] Complejo Hosp Univ Pontevedra, Rheumatol, Pontevedra, Spain
dc.contributor.authoraffiliation[Callejas-Rubio, J. L.] Hosp San Cecilio, Rheumatol, Granada, Spain
dc.contributor.authoraffiliation[De Miguel, E.] Hosp La Paz, Rheumatol, Madrid, Spain
dc.contributor.authoraffiliation[Galindez-Agirregoikoa, E.] Hosp Basurto, Rheumatol, Bilbao, Spain
dc.contributor.authoraffiliation[Sivera, F.] Hosp Univ Elda, Rheumatol, Alicante, Spain
dc.contributor.authoraffiliation[Fernandez-Lopez, C.] Hosp Univ Juan Canalejo, Rheumatol, La Coruna, Spain
dc.contributor.authoraffiliation[Galisteo, C.] Hosp Parc Tauli, Rheumatol, Barcelona, Spain
dc.contributor.authoraffiliation[Ferraz-Amaro, I.] Complejo Hosp Univ Canarias, Rheumatol, Tenerife, Spain
dc.contributor.authoraffiliation[Hernandez, J. L.] Hosp Univ Marques Valdecilla, Internal Med, Santander, Spain
dc.date.accessioned2023-05-03T13:30:39Z
dc.date.available2023-05-03T13:30:39Z
dc.date.issued2022-06-01
dc.identifier.doi10.1136/annrheumdis-2022-eular.3260
dc.identifier.essn1468-2060
dc.identifier.issn0003-4967
dc.identifier.unpaywallURLhttps://ard.bmj.com/content/annrheumdis/81/Suppl_1/379.2.full.pdf
dc.identifier.urihttp://hdl.handle.net/10668/20096
dc.identifier.wosID850279001211
dc.issue.number1
dc.journal.titleAnnals of the rheumatic diseases
dc.journal.titleabbreviationAnn. rheum. dis.
dc.language.isoen
dc.organizationHospital Universitario San Cecilio
dc.organizationHospital Universitario San Cecilio
dc.page.number379-380
dc.publisherBmj publishing group
dc.rights.accessRightsopen access
dc.titleINTRAVENOUS VERSUS SUBCUTANEOUS TOCILIZUMAB IN A SERIES OF 471 PATIENTS WITH GIANT CELL ARTERITIS
dc.typeconference output
dc.type.hasVersionVoR
dc.volume.number81
dc.wostypeMeeting Abstract
dspace.entity.typePublication

Files

Collections

SAS - Hospital Universitario San Cecilio

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía